Skip to main content

Find Clinical Trials

Home
Conditions
Carcinoma

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,758 public trials 2,076 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma trial results

Active, Not Recruiting

Toripalimab Plus Bevacizumab Combined Three Intra-arterial Therapies (TACE, HAIC, or TACE-HAIC) for Unresectable Hepatocellular Carcinoma: a Phase 2, Multicenter Randomised Non-comparative Trial

NCT07380633

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, China

View Trial Details

Active, Not Recruiting

Neoadjuvant and Adjuvant Lenvatinib in HCC Patients Treated by Percutaneous Ablative

NCT05113186

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: NAHON Bobigny, France

View Trial Details

Active, Not Recruiting

TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC

NCT02065362

Conditions: Bone Diseases, Bone Diseases, Developmental, Camurati-Engelmann Syndrome, +19 more
Locations: Texas Children's Hospital Houston, Texas, United States

View Trial Details

Active, Not Recruiting

UCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint Blockade

NCT03474497

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +37 more
Locations: UC Davis Medical Center Sacramento, California, United States

University of California Davis Medical Center Sacramento, California, United States

View Trial Details

Active, Not Recruiting

TACE With or Without SBRT as Bridging Therapy for Pre-transplant HCC Patients

NCT01918683

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Loyola University Medical Center Maywood, Illinois, United States

Oregon Health & Science University Portland, Oregon, United States

Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Active, Not Recruiting

Efficacy Study of Pembrolizumab in Relapsed, Locally Recurrent Squamous Cell Cancer of the Head and Neck

NCT02769520

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations: UCSD Moores Cancer Center La Jolla, California, United States

University of California San Francisco San Francisco, California, United States

University of California Los Angeles Torrance, California, United States

View Trial Details

Active, Not Recruiting

Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer

NCT05340673

Conditions: Adenocarcinoma, Breast Carcinoma In Situ, Breast Ductal Carcinoma in Situ, +8 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

Pembrolizumab Plus Olaparib in LA-HNSCC

NCT05366166

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations: Indiana University Simon Comprehensive Cancer Center Indianapolis, Indiana, United States

University of Louisville, Brown Cancer Center Louisville, Kentucky, United States

UNC Lineberger Chapel Hill, North Carolina, United States

Medical University of South Carolina (MUSC) Charleston, South Carolina, United States

View Trial Details

Active, Not Recruiting

Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy

NCT02432963

Conditions: Adenocarcinoma, Adult Solid Neoplasm, Bladder Carcinoma, +74 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

Camrelizumab Combined With or Without Apatinib and SOX of Neoadjuvant Treatment for Gastric Cancer

NCT06693128

Conditions: Adenocarcinoma, Carcinoma, Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma, +3 more
Locations: Sichuan Cancer Hospital & Institute Chengdu, China

Changhai Hospital Shanghai, China

Yantai Yuhuangding Hospital Yantai, China

View Trial Details